We are live on
!
Find out more
Ensign Peak Advisors Portfolio holdings
AUM
$53.7B
1-Year Est. Return
29.47%
This Fund
S&P 500
This Quarter
Est. Return
+4.38%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
–
AUM
$56.3B
AUM Growth
-$596M
(-1%)
Cap. Flow
-$1.62B
Cap. Flow
% of AUM
-2.89%
Top 10 Holdings %
Top 10 Hldgs %
32.29%
Holding
1,743
New
37
Increased
427
Reduced
443
Closed
34
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$304M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$156M |
| 3 |
Monolithic Power Systems
MPWR
|
+$134M |
| 4 |
LyondellBasell Industries
LYB
|
+$128M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$101M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$374M |
| 2 |
Microsoft
MSFT
|
+$253M |
| 3 |
Apple
AAPL
|
+$200M |
| 4 |
Broadcom
AVGO
|
+$198M |
| 5 |
Meta Platforms (Facebook)
META
|
+$193M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.94% |
| 2 | Financials | 13.84% |
| 3 | Healthcare | 12.35% |
| 4 | Consumer Discretionary | 10.61% |
| 5 | Communication Services | 8.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
901
Qualys
QLYS
$4.76B
| $2.19M | ﹤0.01% |
15,644
| – | – |
|
902
Skye Bioscience
SKYE
$21.6M
| $2.17M | ﹤0.01% |
767,287
-132,713
| -15% | -$555K |
|
903
Alaska Air
ALK
$5.11B
| $2.15M | ﹤0.01% |
33,272
| – | – |
|
904
Edgewise Therapeutics
EWTX
$4.28B
| $2.15M | ﹤0.01% |
+80,509
| New | +$2.56M |
|
|
CADE
905
DELISTED
Cadence Bank
CADE
| $2.15M | ﹤0.01% |
62,350
| – | – |
|
906
SiteOne Landscape Supply
SITE
$4.16B
| $2.15M | ﹤0.01% |
16,298
| – | – |
|
907
Gentex
GNTX
$5.1B
| $2.14M | ﹤0.01% |
74,547
-39,319
| -35% | -$1.18M |
|
908
First Industrial Realty Trust
FR
$8.66B
| $2.14M | ﹤0.01% |
42,637
| – | – |
|
909
Robert Half
RHI
$4.11B
| $2.14M | ﹤0.01% |
30,320
-7,080
| -19% | -$505K |
|
910
Valmont Industries
VMI
$8.86B
| $2.13M | ﹤0.01% |
6,952
+981
| +16% | +$316K |
|
911
Praxis Precision Medicines
PRAX
$8.11B
| $2.13M | ﹤0.01% |
+27,650
| New | +$2M |
|
912
EXL Service
EXLS
$5.5B
| $2.13M | ﹤0.01% |
47,941
| – | – |
|
913
Badger Meter
BMI
$3.87B
| $2.12M | ﹤0.01% |
9,998
| – | – |
|
914
Itron
ITRI
$4.54B
| $2.11M | ﹤0.01% |
19,452
| – | – |
|
915
Universal Display
OLED
$3.75B
| $2.11M | ﹤0.01% |
14,441
| – | – |
|
916
Essential Properties Realty Trust
EPRT
$6.92B
| $2.11M | ﹤0.01% |
67,381
| – | – |
|
917
Yum China
YUMC
$15.7B
| $2.11M | ﹤0.01% |
43,750
| – | – |
|
918
Stride
LRN
$4.16B
| $2.1M | ﹤0.01% |
20,249
| – | – |
|
919
Mine Safety
MSA
$6.79B
| $2.1M | ﹤0.01% |
12,667
| – | – |
|
920
Stellantis
STLA
$17.4B
| $2.09M | ﹤0.01% |
160,343
| – | – |
|
921
Voya Financial
VOYA
$8.96B
| $2.08M | ﹤0.01% |
30,292
-700
| -2% | -$54.7K |
|
922
ACI Worldwide
ACIW
$6.12B
| $2.08M | ﹤0.01% |
39,989
+1,695
| +4% | +$90.2K |
|
923
Rocket Lab Corp
RKLB
$36.6B
| $2.07M | ﹤0.01% |
81,450
+8,900
| +12% | +$156K |
|
924
Starwood Property Trust
STWD
$6.12B
| $2.07M | ﹤0.01% |
109,353
| – | – |
|
925
GeneDx Holdings
WGS
$1.89B
| $2.07M | ﹤0.01% |
+26,900
| New | +$1.88M |
|
Similar funds
SCP
Ensign Peak Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, Ensign Peak Advisors held 1,743 positions worth $56.3B, down 1% from $56.9B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Trading was light in Q4 2024: portfolio turnover was 4.1%. Ensign Peak Advisors opened 37 new positions and exited 34, leaving the 1,743-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 30% a quarter earlier, followed by Financials and Healthcare.
- Ensign Peak Advisors's largest Q4 2024 buy was State Street SPDR S&P 500 ETF Trust: 515,457 shares worth $302M.
- Ensign Peak Advisors added most to iShares Core S&P 500 ETF in Q4 2024, an estimated $156M increase.
- Ensign Peak Advisors's biggest Q4 2024 reduction was NVIDIA, cutting an estimated $374M.
- Ensign Peak Advisors fully exited NewAmsterdam Pharma in Q4 2024, selling an estimated $4.08M.
- Ensign Peak Advisors's ten largest holdings make up 32% of its $56.3B portfolio in Q4 2024.
- Ensign Peak Advisors opened 37 new positions and closed 34 in Q4 2024.
- Ensign Peak Advisors's portfolio value fell 1% quarter-over-quarter to $56.3B.
Based on Ensign Peak Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.